The Pershing Square Sohn Cancer Research Alliance is now accepting applications for its 2024 Prize for Rising Leaders in Cancer Research.
Donor Name: Pershing Square Sohn Cancer Research Alliance (PSSCRA)
State: New York, New Jersey and Connecticut
County: Selected Counties
City: New York City
Borough: Bronx, Brooklyn, Manhattan, Queens, and Staten Island
Type of Grant: Prize
Deadline: 10/30/2023
Size of the Grant: $250,000
Grant Duration: 3 years
Details:
Now providing funding and support for 66 investigators at 13 academic research institutions, the highly competitive Pershing Square Sohn Prize underwrites the bold research of cancer scientists at a formative stage in their careers. In order to facilitate collaboration and innovation, each Prize winner is given access to leaders in the pharmaceutical and biotech industries and the opportunity to present his or her work to scientific, business, and philanthropic audiences.
The Pershing Square Sohn Cancer Research Alliance (PSSCRA) is dedicated to accelerating cures for cancer by advancing the pursuit of innovative cancer research and by facilitating collaborations between the science and business communities. PSSCRA seeks to guide philanthropic funds to feed critical scientific discoveries, attracting like-minded investors to the cause of fighting cancer and creating a pipeline for earlystage biomedical investments.
In addition to receiving funding, Prize winners are given access to a unique network and are invited to participate in select programs, including:
- Facilitated partnerships with other researchers within and across institutions
- Networking programs (including but not limited to: collaborations/discussions between Prize winners and industry mentors, introductions to philanthropic and for-profit investors in the business community, invitations to special industry networking and entrepreneurship events, and more)
- Annual retreat
- Ability to present the best ideas at conferences and events (hosted by PSSCRA and other organizations).
Funding Information
The prize of $250,000 per year for three years is awarded annually to at least six New York City area-based scientists. The Prize empowers researchers to pursue novel, high-risk/high-reward cancer research at a stage when traditional funding is lacking.
Eligibility Criteria
- An MD, PhD, MD-PhD degree (or equivalent) is required. Applicants must have at least two (2) years of experience running their own laboratories but no more than six (6) years of experience by the start date of the Prize (July 2024). Exceptions due to prolonged medical or family leave will be considered on a caseby-case basis.
- Principal Investigators (PIs) must hold faculty appointments at academic research institutions in the greater New York City area at the level of Assistant or Associate Professor (or equivalent). The greater New York City area includes New York City’s five boroughs, Long Island, Westchester County, New Jersey, and Western Connecticut (including Fairfield and New Haven Counties). Applicants may only apply to the Prize a total of two (2) times.
- An applicant who is not a U.S. citizen or permanent resident, by submitting an application for this funding, assures that his/her visa status will provide sufficient time to complete the project and grant term within the United States. Investigators need not be specifically trained in cancer research; however, they should be working in an environment capable of conducting high-quality, high-impact cancer research.
For more information, visit PSSCRA.
